Proton therapy or photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer

Bookmark and Share
Published: 6 Jun 2019
Views: 372
Rating:
Save
Prof Brian Baumann - Washington University in St. Louis, St. Louis, USA

Prof Brian Baumann talks to ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about a comparative effectiveness study comparing proton therapy or photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer.

He explains that the hypotheses of the study was that proton therapy would reduce the side effects without reduction in the cancer control outcomes.

Prof Baumann reports that 1500 patients were studied across a range of cancers, with toxicity data gathered prospectively and then analysed

That analysis showed a 2/3 reduction in rates of grade 3 and higher toxicities in favour of proton therapy.